Quick Answer
Microvast Holdings, Inc. reported Research And Development Expense of $34.11 million for the year ending 2025.
- Microvast Holdings, Inc. showed a decrease of -16.9% in Research And Development Expense from 2024 to 2025.
- This data is from Microvast Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $4.56 million | Q1 2021: $3.79 million | Q2 2021: $5.90 million | Q3 2021: $13.52 million | Q1 2022: $11.31 million | Q2 2022: $10.24 million | Q3 2022: $11.46 million | Q1 2023: $10.86 million | Q2 2023: $9.51 million | Q3 2023: $13.24 million | Q1 2024: $11.49 million | Q2 2024: $10.11 million | Q3 2024: $10.69 million | Q1 2025: $8.25 million | Q2 2025: $7.72 million | Q3 2025: $7.76 million.
- Over the full 7 years of available data (2019 to 2025), Microvast Holdings, Inc.'s Research And Development Expense has grown by 31.2%.
- Historical annual values: Fiscal year 2025: $34.11 million | Fiscal year 2024: $41.07 million | Fiscal year 2023: $45.00 million | Fiscal year 2022: $43.51 million | Fiscal year 2021: $34.39 million | Fiscal year 2020: $16.64 million | Fiscal year 2019: $26.00 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: